These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31909172)

  • 1. Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance.
    Dang C; Yassi N; Harrington KD; Xia Y; Lim YY; Ames D; Laws SM; Hickey M; Rainey-Smith S; Sohrabi HR; Doecke JD; Fripp J; Salvado O; Snyder PJ; Weinborn M; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    Alzheimers Dement (Amst); 2019 Dec; 11():566-575. PubMed ID: 31909172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.
    Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith SR; Robertson J; Rowe CC; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Masters CL; Maruff P;
    Arch Clin Neuropsychol; 2019 Jul; 34(5):585-598. PubMed ID: 30272115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ
    Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain structure and phenotypic profile of superagers compared with age-matched older adults: a longitudinal analysis from the Vallecas Project.
    Garo-Pascual M; Gaser C; Zhang L; Tohka J; Medina M; Strange BA
    Lancet Healthy Longev; 2023 Aug; 4(8):e374-e385. PubMed ID: 37454673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
    Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
    Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.
    Ghisays V; Goradia DD; Protas H; Bauer RJ; Devadas V; Tariot PN; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Caselli RJ; Su Y; Chen K; Reiman EM
    Alzheimers Dement; 2020 Apr; 16(4):598-609. PubMed ID: 31831374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
    Fonseca CS; Baker SL; Dobyns L; Janabi M; Jagust WJ; Harrison TM
    Alzheimers Dement; 2024 Apr; 20(4):2526-2537. PubMed ID: 38334195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
    Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.
    Bangen KJ; Clark AL; Edmonds EC; Evangelista ND; Werhane ML; Thomas KR; Locano LE; Tran M; Zlatar ZZ; Nation DA; Bondi MW; Delano-Wood L
    Front Aging Neurosci; 2017; 9():181. PubMed ID: 28642699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.
    Chen X; Cassady KE; Adams JN; Harrison TM; Baker SL; Jagust WJ
    J Neurosci; 2021 Jan; 41(2):366-375. PubMed ID: 33219003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthreshold Amyloid Predicts Tau Deposition in Aging.
    Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
    J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.
    Yassi N; Hilal S; Xia Y; Lim YY; Watson R; Kuijf H; Fowler C; Yates P; Maruff P; Martins R; Ames D; Chen C; Rowe CC; Villemagne VL; Salvado O; Desmond PM; Masters CL
    J Alzheimers Dis; 2020; 73(3):897-907. PubMed ID: 31884485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.
    Zhao Y; Tudorascu DL; Lopez OL; Cohen AD; Mathis CA; Aizenstein HJ; Price JC; Kuller LH; Kamboh MI; DeKosky ST; Klunk WE; Snitz BE
    JAMA Neurol; 2018 Jan; 75(1):88-96. PubMed ID: 29114732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-old.
    Pelkmans W; Legdeur N; Ten Kate M; Barkhof F; Yaqub MM; Holstege H; van Berckel BNM; Scheltens P; van der Flier WM; Visser PJ; Tijms BM
    Ann Clin Transl Neurol; 2021 Feb; 8(2):348-358. PubMed ID: 33421355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
    Wirth M; Madison CM; Rabinovici GD; Oh H; Landau SM; Jagust WJ
    J Neurosci; 2013 Mar; 33(13):5553-63. PubMed ID: 23536070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Sleep-Disordered Breathing and Medial Temporal Lobe Atrophy in Cognitively Unimpaired Amyloid-Positive Older Adults.
    André C; Kuhn E; Rehel S; Ourry V; Demeilliez-Servouin S; Palix C; Felisatti F; Champetier P; Dautricourt S; Yushkevich P; Vivien D; de La Sayette V; Chételat G; de Flores R; Rauchs G;
    Neurology; 2023 Jul; 101(4):e370-e385. PubMed ID: 37258299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.